{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:01:00Z","timestamp":1785564060509,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.intimp.2012.02.002","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T06:47:15Z","timestamp":1329806835000},"page":"565-572","source":"Crossref","is-referenced-by-count":47,"title":["Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: Role of TLR4 and TLR9"],"prefix":"10.1016","volume":"12","author":[{"given":"Asok Kumar","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Kar Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchandra","family":"Bhattacharyya Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2012.02.002_bb0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0738-081X(99)00050-4","article-title":"Global control and Leishmania HIV co-infection","volume":"17","author":"Desjeux","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.intimp.2012.02.002_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.intimp.2012.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3201\/eid0912.030178","article-title":"Visceral leishmaniasis treatment","volume":"9","author":"Gradoni","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.intimp.2012.02.002_bb0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2012.02.002_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00685608","article-title":"Alkylphosphocholines: a new class of membrane-active anticancer agents","volume":"32","author":"Hilgard","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0045","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2001.19.21.4150","article-title":"Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer","volume":"19","author":"Leonard","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0050","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2012.02.002_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11908-003-0063-1","article-title":"Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis","volume":"5","author":"Pearson","year":"2003","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.intimp.2012.02.002_bb0060","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2012.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2012.02.002_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0005-2760(97)00163-X","article-title":"The inhibition of cell signaling pathways by antitumor ether lipids","volume":"1390","author":"Arthur","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.intimp.2012.02.002_bb0075","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.45.6.1872-1875.2001","article-title":"Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice","volume":"45","author":"Escobar","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.intimp.2012.02.002_bb0080","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/605895","article-title":"CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response","volume":"200","author":"Gupta","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2012.02.002_bb0090","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/IAI.01388-10","article-title":"Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis","volume":"79","author":"Gallego","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.02.002_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0952-7915(97)80152-5","article-title":"Innate immunity: impact on the adaptive immune response","volume":"9","author":"Medzhitov","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1189\/jlb.1103543","article-title":"Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system","volume":"75","author":"Netea","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-3024.2010.01243.x","article-title":"The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma","volume":"32","author":"Tuon","year":"2010","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0110","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/IAI.72.4.1920-1928.2004","article-title":"Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major","volume":"72","author":"Kropf","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.02.002_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/653210","article-title":"Arabinosylated lipoarabinomannan-mediated protection in visceral leishmaniasis through up-regulation of toll-like receptor 2 signaling: an immunoprophylactic approach","volume":"202","author":"Bhattacharya","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2012.02.002_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1017\/S0031182000066889","article-title":"A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers","volume":"82","author":"Hart","year":"1981","journal-title":"Parasitology"},{"key":"10.1016\/j.intimp.2012.02.002_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jinf.2010.05.003","article-title":"Amphotericin B regulates the host immune response in visceral leishmaniasis: reciprocal regulation of protein kinase C isoforms","volume":"61","author":"Mukherjee","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.intimp.2012.02.002_bb0130","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1086\/340820","article-title":"Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide","volume":"185","author":"Bhattacharyya","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2012.02.002_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.intimp.2012.02.002_bb0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF01612758","article-title":"Investigation into the immunological effects of miltefosine, a new anticancer agent under development","volume":"117","author":"Hilgard","year":"1991","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0008-8749(92)90135-C","article-title":"Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF mRNA in human mononuclear cells","volume":"141","author":"Hochhuth","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1359-4117.2002.01048.x","article-title":"Hexadecylphosphocholine selectively upregulates expression of intracellular adhesion molecule-1 and class I major histocompatibility complex antigen in human monocytes","volume":"2","author":"Eue","year":"2002","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0230","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/IAI.01090-07","article-title":"Toll-like receptors and leishmaniasis","volume":"76","author":"Tuon","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.02.002_bb0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.1636092","article-title":"Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism","volume":"257","author":"Barral-Netto","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.intimp.2012.02.002_bb0165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2249.2008.03741.x","article-title":"Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage\/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism","volume":"154","author":"Chandra","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jdermsci.2010.04.009","article-title":"The expression of TLR2, TLR4 and TLR9 in the epidermis of patients with cutaneous leishmaniasis","volume":"59","author":"Tuon","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2012.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdan","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0180","doi-asserted-by":"crossref","first-page":"L918","DOI":"10.1152\/ajplung.00381.2003","article-title":"Toll-like receptors and TLR-mediated signaling: more questions than answers","volume":"286","author":"Pan","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0185","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1000238","article-title":"Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis","volume":"185","author":"Raman","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4049\/jimmunol.1002175","article-title":"Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages","volume":"186","author":"Faria","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2613.2010.00717.x","article-title":"Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis","volume":"91","author":"Guerra","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0235","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4049\/jimmunol.182.3.1386","article-title":"TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions","volume":"182","author":"Abou Fakher","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.molimm.2007.02.021","article-title":"TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells","volume":"45","author":"Theiner","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.intimp.2012.02.002_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.a.21001","article-title":"Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis","volume":"79","author":"Sarkar","year":"2011","journal-title":"Cytometry A"},{"key":"10.1016\/j.intimp.2012.02.002_bb0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cyto.2008.08.017","article-title":"Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol","volume":"44","author":"Manna","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2012.02.002_bb0220","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jac\/dkq164","article-title":"CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis","volume":"65","author":"Sane","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.002_bb0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4+CD25\u2212Foxp3\u2212 Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J Exp Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:24:32Z","timestamp":1543191872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1567576912000549"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.02.002","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}